Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-07-07
1994-04-12
Fay, Zohreh A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514378, 514636, A61K 31505, A61K 3142, A61K 31155
Patent
active
053025989
ABSTRACT:
The present invention provides methods for treating and preventing the onset of Pneumocystis carinii pneumonia (PCP) comprising administering to a mammal in need of such treatment or prevention an effective amount of a pharmaceutically acceptable iron chelator. This invention also provides a method for treating or preventing the onset of PCP comprising administering to a mammal in need of such treatment or prevention a composition comprising the following components: (a) a pharmaceutically acceptable iron chelator; (b) a compound selected from trimethoprim/sulfamethoxazole and pentamidine; and (c) a pharmaceutically compatible carrier or diluent, wherein the amounts of said component (a) and said component (b) in combination are effective in treating said pneumonia. Also provided is a composition for the treatment or prevention of PCP.
REFERENCES:
patent: 2410796 (1986-11-01), Newberry et al.
patent: 3049544 (1962-08-01), Stenbuck et al.
patent: 3341541 (1967-09-01), Hoffer
patent: 4419365 (1983-12-01), McLachlan
patent: 4614797 (1986-11-01), Nagata et al.
Jones et al., Nature, 267:63-64, 1987.
Chiu et al., Brit. Med. J., 292:97, 1986.
Mazzoleni et al., Diges. Dis. and Sci., 36:1155-1160, 1991.
Boelaert et al., Am. J. Kidney Dis., 18:660-667, 1991.
Daly et al., Am. J. Med., 87:468-471, 1989.
Weinberg et al., Blood, 68:286A, 1986.
Carotenuto et al., J. of Immunol., 136:2342-2347, 1986.
Lederman et al., Blood, 64:748-753, 1984.
Lowy et al., Animicrob. Agents Chemotherap., 25:375-376, 1984.
Vandenbergh et al., Appl. and Environ. Microbiol., 46:128-132, 1983.
Gallant et al., New Eng. J. Med., 314:1643, 1986.
Kouides et al., Brit. J. Haematol., 70:382-383, 1988.
Hughes, N. Eng. J. Med., 317:1021-1023, 1987.
Edman et al., Nature, 334:519-522, 1988.
Haverkos, Am. J. Med., 76:501-508, 1984.
Jones et al., Eur. J. Clin. Microbiol., 2:411-413, 1983.
Youdim, Am. Rev. Resp. Dis., 99:925-931 (Abstract only). 1969.
Schafer et al., Arch. Intern. Med., 145:1217-1221, 1985.
Fritsch et al., Exp. Parisitol, 60:171-174, 1985.
Graziano et al., J. Ped., 92(4):648-652, 1978.
Peto et al., Br. J. Haematol., 63:273-280, 1986.
Hynes, J. Med. Chem., 13:1235-1237, 1970.
Pollack et al., Proc. Soc. Exp. Biol. Med., 184:162-164, 1987.
Raventos-Suraez et al., Am. J. Trop. Med. Hvg., 3(5):919-922, 1982.
Queener et al., Antimicrobial Agents and Chemotherapy, 31:1323-1327, 1987.
Queener et al., Antimicrobial Agents and Chemotherapy, 32:807-813, 1988.
Masawe et al., Lancet, 2:314-317, 1974.
Sattler et al., Annals of Internal Medicine, 109:208-287, 1988.
Kovacs et al., Journal of Infectious Diseases, 158:254-259, 1988.
Clarkson et al., Antimicrobial Agents and Chemotherapy, 32:1158-1163, 1988.
Green et al., British Journal of Clinical Pharmacology, 487-491, 1988.
Allegra et al., New England Journal of Medicine, 317:978-985, 1987.
Gallacher et al., Critical Care Medicine, 17:104-105, 1989.
Clarkson, Jr. Allen B.
Grady Robert W.
Fay Zohreh A.
New York University
LandOfFree
Method and compositions for treating Pneumocystic carinii infect does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and compositions for treating Pneumocystic carinii infect, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for treating Pneumocystic carinii infect will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2098870